Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hypolipidemic compounds reported by Aventis in recent patent

April 18, 2001

Maxia describes series useful in diabetes and hyperproliferative disorders

April 17, 2001

Pfizer's somatostatin antagonists enhance GH secretion

April 17, 2001

Phase III Oxygent trial shows benefit in reducing and avoiding blood transfusions

April 17, 2001

Phytopharm's P-57 well tolerated in first stage of proof-of-principle trial

April 12, 2001

U.S. patent covers altered peptide ligands, including NBI-6024, and use in diabetes Rx

April 12, 2001

Spiro compounds for eating or metabolic disorders disclosed by Banyu

April 11, 2001

Hemopure approved for the first time in South Africa

April 11, 2001

3-D structure of GR determined as part of Karo Bio and Abbott collaboration

April 11, 2001

NPY antagonists with selectivity for Y5 receptors and their use in eating disorders

April 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...